The role of macrophage phenotype in vascularization of tissue engineering scaffolds

Biomaterials

Volumn 35, Issue 15, 2014, Pages 4477-4488

  Spiller, Kara L ^a,b   Anfang, Rachel R ^a   Spiller, Krista J ^c   Ng, Johnathan ^a   Nakazawa, Kenneth R ^a   Daulton, Jeffrey W ^d   Vunjak Novakovic, Gordana ^a  

^a Department of Earth and Environmental Sciences   (United States)

^b DREXEL UNIVERSITY   (United States)

^c Department of Pathology Columbia University ^*  (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Angiogenesis; Collagen; Foreign body response; Inflammation; Macrophage

Indexed keywords

BLOOD VESSELS; COLLAGEN; ENDOTHELIAL CELLS; IMPLANTS (SURGICAL); SCAFFOLDS (BIOLOGY);

ANGIOGENESIS; FOREIGN BODY RESPONSE; IMPLANTATION MODELS; INFLAMMATION; INFLAMMATORY RESPONSE; LIPOPOLYSACCHARIDES; MACROPHAGE PHENOTYPES; TISSUE ENGINEERING SCAFFOLD;

MACROPHAGES;

COLLAGEN; CYTOKINE; GELATINASE B; GLUTARALDEHYDE; MOLECULAR SCAFFOLD; PLATELET DERIVED GROWTH FACTOR BB; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TISSUE ENGINEERING;

BACTERIA (MICROORGANISMS); MURINAE;

ANGIOGENESIS; COLLAGEN; FOREIGN BODY RESPONSE; INFLAMMATION; MACROPHAGE;

ANIMALS; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-SIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896055839     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.02.012     Document Type: Article

References (86)

1. Roh J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010, 107(10):4669-4674.
2. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. JExp Med 1992, 176(1):287-292.
3. Chung E.S., Chauhan S.K., Jin Y., Nakao S., Hafezi-Moghadam A., van Rooijen N., et al. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol 2009, 175(5):1984-1992.
4. van Amerongen M.J., Harmsen M.C., van Rooijen N., Petersen A.H., van Luyn M.J. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007, 170(3):818-829.
5. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124(2):263-266.
6. Godwin J.W., Pinto A.R., Rosenthal N.A. Macrophages are required for adult salamander limb regeneration. Proc Natl Acad Sci U S A 2013, 110(23):9415-9420.
7. Krishnamoorthy L. The role of macrophages in human wound healing and their response to a tissue engineered dermal replacement in human chronic wounds 2006, [MD Thesis], University of Glasgow.
8. Khallou-Laschet J., Varthaman A., Fornasa G., Compain C., Gaston A.T., Clement M., et al. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010, 5(1):e8852.
9. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. JNeurosci 2009, 29(43):13435-13444.
10. Lu J., Cao Q., Zheng D., Sun Y., Wang C., Yu X., et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int 2013, 84(4):745-755.
11. Wang Y., Wang Y.P., Zheng G., Lee V.W., Ouyang L., Chang D.H., et al. Exvivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007, 72(3):290-299.
12. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23(11):549-555.
13. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008, 14(11):1835-1842.
14. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30(8):1482-1491.
15. Madden L.R., Mortisen D.J., Sussman E.M., Dupras S.K., Fugate J.A., Cuy J.L., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 2010, 107(34):15211-15216.
16. Zhang L., Cao Z., Bai T., Carr L., Ella-Menye J.R., Irvin C., et al. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol 2013, 31(6):553-556.
17. Fishman J.M., Lowdell M.W., Urbani L., Ansari T., Burns A.J., Turmaine M., et al. Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A 2013, 110(35):14360-14365.
18. Tous E., Weber H.M., Lee M.H., Koomalsingh K.J., Shuto T., Kondo N., et al. Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking. Acta Biomater 2012, 8(9):3218-3227.
19. Bota P.C., Collie A.M., Puolakkainen P., Vernon R.B., Sage E.H., Ratner B.D., et al. Biomaterial topography alters healing invivo and monocyte/macrophage activation invitro. JBiomed Mater Res A 2010, 95(2):649-657.
20. Tolg C., Hamilton S.R., Zalinska E., McCulloch L., Amin R., Akentieva N., et al. ARHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds. Am J Pathol 2012, 181(4):1250-1270.
21. Szekanecz Z., Koch A.E. Mechanisms of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol 2007, 3(11):635-643.
22. Cao X., Shen D., Patel M.M., Tuo J., Johnson T.M., Olsen T.W., et al. Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int 2011, 61(9):528-535.
23. Fuentes-Duculan J., Suarez-Farinas M., Zaba L.C., Nograles K.E., Pierson K.C., Mitsui H., et al. Asubpopulation of CD163-positive macrophages is classically activated in psoriasis. JInvest Dermatol 2010, 130(10):2412-2422.
24. Costa C., Incio J., Soares R. Angiogenesis and chronic inflammation: cause or consequence?. Angiogenesis 2007, 10(3):149-166.
25. Peng B., Hao J., Hou S., Wu W., Jiang D., Fu X., et al. Possible pathogenesis of painful intervertebral disc degeneration. Spine (Phila Pa 1976) 2006, 31(5):560-566.
26. Hutter R., Speidl W.S., Valdiviezo C., Sauter B., Corti R., Fuster V., et al. Macrophages transmit potent proangiogenic effects of oxLDL invitro and invivo involving HIF-1alpha activation: a novel aspect of angiogenesis in atherosclerosis. JCardiovasc Transl Res 2013, 6(4):558-569.
27. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25(12):677-686.
28. Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. JExp Med 2007, 204(5):1057-1069.
29. Troidl C., Mollmann H., Nef H., Masseli F., Voss S., Szardien S., et al. Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. JCell Mol Med 2009, 13(9B):3485-3496.
30. Seager Danciger J., Lutz M., Hama S., Cruz D., Castrillo A., Lazaro J., et al. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. JImmunol Methods 2004, 288(1-2):123-134.
31. Kelley J.L., Rozek M.M., Suenram C.A., Schwartz C.J. Activation of human blood monocytes by adherence to tissue culture plastic surfaces. Exp Mol Pathol 1987, 46(3):266-278.
32. Baudin B., Bruneel A., Bosselut N., Vaubourdolle M. Aprotocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2007, 2(3):481-485.
33. Preibisch S., Saalfeld S., Tomancak P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 2009, 25(11):1463-1465.
34. Carpentier G. ImageJ contribution: angiogenesis analyzer. ImageJ News 2012, 5.
35. Bartneck M., Heffels K.H., Pan Y., Bovi M., Zwadlo-Klarwasser G., Groll J. Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres. Biomaterials 2012, 33(16):4136-4146.
36. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. JImmunol 2006, 177(10):7303-7311.
37. Yoshida A., Anand-Apte B., Zetter B.R. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 1996, 13(1-2):57-64.
38. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18(14):3964-3972.
39. Martin D., Galisteo R., Gutkind J.S. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. JBiol Chem 2009, 284(10):6038-6042.
40. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258(5089):1798-1801.
41. Suffee N., Hlawaty H., Meddahi-Pelle A., Maillard L., Louedec L., Haddad O., et al. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 2012, 15(4):727-744.
42. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496(7446):445-455.
43. Sainson R.C., Johnston D.A., Chu H.C., Holderfield M.T., Nakatsu M.N., Crampton S.P., et al. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008, 111(10):4997-5007.
44. Yoshizumi M., Kourembanas S., Temizer D.H., Cambria R.P., Quertermous T., Lee M.E. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. JBiol Chem 1992, 267(14):9467-9469.
45. Stratman A.N., Schwindt A.E., Malotte K.M., Davis G.E. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010, 116(22):4720-4730.
46. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126(14):3047-3055.
47. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., et al. The invitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25(7):1737-1745.
48. Hellberg C., Ostman A., Heldin C.H. PDGF and vessel maturation. Recent Results Cancer Res 2010, 180:103-114.
49. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407(6801):242-248.
50. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., et al. Anovel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003, 9(4):407-415.
51. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8(2):205-216.
52. Jadhav U., Chigurupati S., Lakka S.S., Mohanam S. Inhibition of matrix metalloproteinase-9 reduces invitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 2004, 25(5):1407-1414.
53. Ardi V.C., Kupriyanova T.A., Deryugina E.I., Quigley J.P. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A 2007, 104(51):20262-20267.
54. Ebrahem Q., Chaurasia S.S., Vasanji A., Qi J.H., Klenotic P.A., Cutler A., et al. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization invivo. Am J Pathol 2010, 176(1):496-503.
55. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116(5):829-840.
56. Outtz H.H., Tattersall I.W., Kofler N.M., Steinbach N., Kitajewski J. Notch1 controls macrophage recruitment and Notch signaling is activated at sites of endothelial cell anastomosis during retinal angiogenesis in mice. Blood 2011, 118(12):3436-3439.
57. Ju Y.M., Yu B., West L., Moussy Y., Moussy F. Anovel porous collagen scaffold around an implantable biosensor for improving biocompatibility. II. Long-term invitro/invivo sensitivity characteristics of sensors with NDGA- or GA-crosslinked collagen scaffolds. JBiomed Mater Res A 2010, 92(2):650-658.
58. Mao Z., Shi H., Guo R., Ma L., Gao C., Han C., et al. Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor. Acta Biomater 2009, 5(8):2983-2994.
59. Stevens K.R., Einerson N.J., Burmania J.A., Kao W.J. Invivo biocompatibility of gelatin-based hydrogels and interpenetrating networks. JBiomater Sci Polym Ed 2002, 13(12):1353-1366.
60. Kitajewski J. Wnts heal by restraining angiogenesis. Blood 2013, 121(13):2381-2382.
61. Kiriakidis S., Andreakos E., Monaco C., Foxwell B., Feldmann M., Paleolog E. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. JCell Sci 2003, 116(Pt 4):665-674.
62. Takeda Y., Costa S., Delamarre E., Roncal C., Leite de Oliveira R., Squadrito M.L., et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011, 479(7371):122-126.
63. Anders H.J., Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011, 80(9):915-925.
64. Matull W.R., Dhar D.K., Ayaru L., Sandanayake N.S., Chapman M.H., Dias A., et al. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011, 31(1):99-107.
65. Pereira T.A., Xie G., Choi S.S., Syn W.K., Voieta I., Lu J., et al. Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni. Liver Int 2013, 33(1):149-161.
66. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32(28):6692-6709.
67. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11(11):723-737.
68. Low-Marchelli J.M., Ardi V.C., Vizcarra E.A., van Rooijen N., Quigley J.P., Yang J. Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res 2013, 73(2):662-671.
69. Kubota Y., Takubo K., Shimizu T., Ohno H., Kishi K., Shibuya M., et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. JExp Med 2009, 206(5):1089-1102.
70. Arendt L.M., McCready J., Keller P.J., Baker D.D., Naber S.P., Seewaldt V., et al. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res 2013, 73(19):6080-6093.
71. Sakurai E., Anand A., Ambati B.K., van Rooijen N., Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003, 44(8):3578-3585.
72. Hibino N., Yi T., Duncan D.R., Rathore A., Dean E., Naito Y., et al. Acritical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 2011, 25(12):4253-4263.
73. Hisatome T., Yasunaga Y., Yanada S., Tabata Y., Ikada Y., Ochi M. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells. Biomaterials 2005, 26(22):4550-4556.
74. Hirose N., Maeda H., Yamamoto M., Hayashi Y., Lee G.H., Chen L., et al. The local injection of peritoneal macrophages induces neovascularization in rat ischemic hind limb muscles. Cell Transplant 2008, 17(1-2):211-222.
75. Herbert S.P., Stainier D.Y. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 2011, 12(9):551-564.
76. He H., Xu J., Warren C.M., Duan D., Li X., Wu L., et al. Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages. Blood 2012, 120(15):3152-3162.
77. Eirin A., Zhu X.Y., Li Z., Ebrahimi B., Zhang X., Tang H., et al. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol 2013, 33(5):1006-1013.
78. Baer C., Squadrito M.L., Iruela-Arispe M.L., De Palma M. Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp Cell Res 2013, 319(11):1626-1634.
79. Agrawal H., Tholpady S.S., Capito A.E., Drake D.B., Katz A.J. Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices. Open J Regen Med 2012, 1(3):51-59.
80. Anderson J.M. Invitro and invivo monocyte, macrophage, foreign body giant cell, and lymphocyte interactions with biomaterials. Biological interactions on materials surfaces 2009, 225-245. Springer Science+ Business Media. D.A. Puleo, R. Bizios (Eds.).
81. Kao W.J., McNally A.K., Hiltner A., Anderson J.M. Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) invivo. JBiomed Mater Res 1995, 29(10):1267-1275.
82. McNally A.K., DeFife K.M., Anderson J.M. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Pathol 1996, 149(3):975-985.
83. Lolmede K., Campana L., Vezzoli M., Bosurgi L., Tonlorenzi R., Clementi E., et al. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. JLeukoc Biol 2009, 85(5):779-787.
84. Zizzo G., Hilliard B.A., Monestier M., Cohen P.L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. JImmunol 2012, 189(7):3508-3520.
85. Spiller K.L., Vunjak-Novakovic G. Clinical translation of controlled protein delivery systems for tissue engineering. Drug Deliv Transl Res 2013, 10.1007/s13346-013-0135-1.
86. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Xu W., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110(9):3507-3512.